DoubleChecks

What was claimed

Ivermectin protocol achieves 91.8% cure rate for ovarian cancer, 90% for lymphoma, 90% for lung/breast cancers, and similar high rates for other cancers

Our verdict

Inaccurate

The sources show only cell and animal studies, not a human protocol with a 91.8% cure rate. A 2025 review says its safety and efficacy in gynecologic cancer are unknown and unsupported. Only one active phase 1/2 trial exists for breast cancer (combining ivermectin with immunotherapy). No established cure rates exist for these cancers. Preclinical studies show promise but do not translate to human efficacy.

All 3 AI systems agree9 sources citedChecked Jul 9, 2026

Check your own claim

Paste any statement, headline, or AI answer — 3 independent AIs verify it in seconds, with sources.

Key findings

Ivermectin achieves 90% cure rate for lung/breast cancers

Incorrect90%
1 AI checked

Ivermectin protocol achieves 91.8% cure rate for ovarian cancer, 90% for lymphoma, 90% for lung/breast cancers, and similar high rates for other cancers

Incorrect95%
5 of 6 AIs agree·Perplexity: Misleading

Ivermectin achieves similar high cure rates for other cancers

Misleading85%
1 AI checked

Ivermectin achieves 90% cure rate for lymphoma

Can’t verify60%
1 AI checked

Verified against 9 sources

pmc.ncbi.nlm.nih.govpmc.ncbi.nlm.nih.govresou.osaka-u.ac.jpfrontiersin.orgpatientpower.infobinaytara.orgoncologynewscentral.comsciencedirect.comyoutube.com

Detailed Analysis

The claim is not supported by the provided evidence. The sources describe preclinical lab findings, not human cure rates, and a recent review says ivermectin’s safety and efficacy in gynecologic cancers are unknown and unsupported. Multiple oncology sources also state there is no proven clinical role for ivermectin in cancer treatment.

Why this verdict

  • The claim is not supported by the provided evidence.
  • The sources describe preclinical lab findings, not human cure rates, and a recent review says ivermectin’s safety and efficacy in gynecologic cancers are unknown and unsupported.
  • Multiple oncology sources also state there is no proven clinical role for ivermectin in cancer treatment.

Claims checked

Ivermectin protocol achieves 90% cure rate for lymphoma

Incorrect95%
No provided source supports a lymphoma cure rate from ivermectin. The oncology sources state there is no proven clinical role for ivermectin in cancer treatment.

This claim may mislead readers without added context.

Ivermectin protocol achieves 90% cure rate for lung and breast cancers

Incorrect95%
The results mention preclinical antitumor activity in breast and lung cancer models, but not human cure rates. Recent oncology coverage says there is no evidence in patients that ivermectin decreases cancer growth.

This claim may mislead readers without added context.

Ivermectin protocol achieves 91.8% cure rate for ovarian cancer

Incorrect97%
The sources show only cell and animal studies, not a human protocol with a 91.8% cure rate. A 2025 review says its safety and efficacy in gynecologic cancer are unknown and unsupported.

This claim may mislead readers without added context.

What other AI think

The claim presents specific cure rate percentages as established fact, but ivermectin lacks proven efficacy in human cancer trials. Medical experts caution against its use for gynecologic cancers. The cited percentages appear to conflate self-reported outcomes from an uncontrolled observational study with validated clinical cure rates, which is dangerously misleading for cancer patients.

Why this verdict

  • The claim presents specific cure rate percentages as established fact, but ivermectin lacks proven efficacy in human cancer trials.
  • Medical experts caution against its use for gynecologic cancers.
  • The cited percentages appear to conflate self-reported outcomes from an uncontrolled observational study with validated clinical cure rates, which is dangerously misleading for cancer patients.

Claims checked

Ivermectin achieves 90% cure rate for lung/breast cancers

Incorrect90%
Only one active phase 1/2 trial exists for breast cancer (combining ivermectin with immunotherapy). No established cure rates exist for these cancers. Preclinical studies show promise but do not translate to human efficacy.

This claim may mislead readers without added context.

Ivermectin protocol achieves 91.8% cure rate for ovarian cancer

Incorrect95%
Experts strongly caution against ivermectin use for gynecologic cancers. Ivermectin shows only modest potency in lab studies and is doubtful to show substantial activity in patients when used alone. No human clinical trials support this specific cure rate.

This claim may mislead readers without added context.

Ivermectin achieves similar high cure rates for other cancers

Misleading85%
The claim overgeneralizes from limited observational data. Most evidence is preclinical. Experts state much more research is needed before efficacy in humans can be established. Presenting these as established cure rates is misleading.

This claim may mislead readers without added context.

The statement asserts precise, very high cure rates for multiple cancers from an ivermectin protocol. No reliable clinical trials or regulatory bodies support such cure-rate figures, and major cancer and medical organizations warn there is no evidence ivermectin cures cancer.

Why this verdict

  • The statement asserts precise, very high cure rates for multiple cancers from an ivermectin protocol.
  • No reliable clinical trials or regulatory bodies support such cure-rate figures, and major cancer and medical organizations warn there is no evidence ivermectin cures cancer.

Claims checked

Ivermectin protocol achieves 91.8% cure rate for ovarian cancer, 90% for lymphoma, 90% for lung/breast cancers, and similar high rates for other cancers

Incorrect95%
There are no high-quality, peer-reviewed clinical trials or regulatory approvals showing ivermectin produces ~90% cure rates in ovarian, lymphoma, lung, breast, or other cancers; major oncology groups and fact-checkers state there is no robust evidence that ivermectin cures any human malignancy.

This claim may mislead readers without added context.

Share this result

Try DoubleChecks